Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Androgen receptor outwits prostate cancer drugs.

Literature DB >> 14702629

Androgen receptor outwits prostate cancer drugs.

John T Isaacs, William B Isaacs.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 2004 PMID： 14702629 DOI： 10.1038/nm0104-26

Source DB: PubMed Journal: Nat Med ISSN： 1078-8956 Impact factor: 53.440

Keyword Cloud
Cited

× No keyword cloud information.

50 in total

1. CaM kinase kinase beta-mediated activation of the growth regulatory kinase AMPK is required for androgen-dependent migration of prostate cancer cells.

Authors: Daniel E Frigo; Matthew K Howe; Bryan M Wittmann; Abigail M Brunner; Ian Cushman; Qianben Wang; Myles Brown; Anthony R Means; Donald P McDonnell
Journal: Cancer Res Date: 2010-11-22 Impact factor: 12.701

2. Glucose-regulated protein 78 mediates the anticancer efficacy of shikonin in hormone-refractory prostate cancer cells.

Authors: Li-Jen Kuo; Chien-Yu Huang; Wan-Li Cheng; Chin-Sheng Hung; Chun-Te Wu; Feng-Yen Lin; Yu-Jia Chang; Ming-Te Huang
Journal: Tumour Biol Date: 2015-02-11

3. Identification of a lysosomal pathway that modulates glucocorticoid signaling and the inflammatory response.

Authors: Yuanzheng He; Yong Xu; Chenghai Zhang; Xiang Gao; Karl J Dykema; Katie R Martin; Jiyuan Ke; Eric A Hudson; Sok Kean Khoo; James H Resau; Arthur S Alberts; Jeffrey P MacKeigan; Kyle A Furge; H Eric Xu
Journal: Sci Signal Date: 2011-07-05 Impact factor: 8.192

4. Progression of prostate cancer by synergy of AKT with genotropic and nongenotropic actions of the androgen receptor.

Authors: Li Xin; Michael A Teitell; Devon A Lawson; Andrew Kwon; Ingo K Mellinghoff; Owen N Witte
Journal: Proc Natl Acad Sci U S A Date: 2006-05-08 Impact factor: 11.205

5. The ErbB3-binding protein Ebp1 suppresses androgen receptor-mediated gene transcription and tumorigenesis of prostate cancer cells.

Authors: Yuexing Zhang; Xin-Wei Wang; Danijela Jelovac; Takeo Nakanishi; Myoung-Hee Yu; Damilola Akinmade; Olga Goloubeva; Douglas D Ross; Angela Brodie; Anne W Hamburger
Journal: Proc Natl Acad Sci U S A Date: 2005-06-30 Impact factor: 11.205

Androgen receptor outwits prostate cancer drugs.

1. CaM kinase kinase beta-mediated activation of the growth regulatory kinase AMPK is required for androgen-dependent migration of prostate cancer cells.

2. Glucose-regulated protein 78 mediates the anticancer efficacy of shikonin in hormone-refractory prostate cancer cells.

3. Identification of a lysosomal pathway that modulates glucocorticoid signaling and the inflammatory response.

4. Progression of prostate cancer by synergy of AKT with genotropic and nongenotropic actions of the androgen receptor.

5. The ErbB3-binding protein Ebp1 suppresses androgen receptor-mediated gene transcription and tumorigenesis of prostate cancer cells.

6. Androgen receptor overexpression is neuroprotective in experimental stroke.

7. Down-regulation of androgen-receptor and PSA by phytochemicals.

8. Post-transcriptional regulation of androgen receptor mRNA by an ErbB3 binding protein 1 in prostate cancer.

9. A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responses.

10. Manipulating prohibitin levels provides evidence for an in vivo role in androgen regulation of prostate tumours.